A collaboration between the Cystic Fibrosis Foundation and Deep Science Ventures aims to identify technologies that might overcome the challenges inherent in developing gene therapies for cystic fibrosis (CF). The effort is part of the foundation’s Path to a Cure initiative, a $500 million research program whose focus…

My message is simple: It is a systemic injustice, even ableist, to heap unbearable financial burdens on people with disabilities (PwD). Before I continue: This column doesn’t critique political parties or provide solutions; it raises red flags so others are mobilized to finding solutions. This column focuses on issues…

BX004, a phage therapy candidate for Pseudomonas aeruginosa infections in people with cystic fibrosis (CF), was able to effectively kill a range of antibiotic-resistant bacterial strains under laboratory conditions, new data show. These findings were shared in the poster “Phage therapy for chronic Pseudomonas aeruginosa infections in Cystic Fibrosis…

“My second nephew was just born,” my boss texted me the other day. “If you have any parenting advice, I’ll pass it along.” I sat down to write him a couple of sentences regarding his brother’s first baby. Instead, I wrote this column. I became a mother unexpectedly as a…

The first participants have been dosed in the first clinical trial testing EDT001, an investigational therapy for cystic fibrosis (CF) being developed by Enterprise Therapeutics. The trial is being conducted in healthy participants (without CF) to assess the investigational medicine’s safety profile. “We are excited to be entering…